HF (heart failure) study supports home-haemodynamic monitor:
This article was originally published in Clinica
Executive Summary
Results from a pilot study evaluating the usefulness of Pulse Metric's DynaPulse's noninvasive home-haemodynamic monitor in managing and treating heart failure (HF) patients has produced positive results, the company has reported. The study of 10 patients has been underway for around six months. It revealed a significant benefit from home-haemodynamic monitoring in at least half of the patients by facilitating early intervention, improved patient management and patient compliance, and overall improved cost-effectiveness in managing, intervening, and treating the patients, says the San Diego, California firm. DynaPulse is to start a 50-patient study to further evaluate the technology in HF patients.